These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6229522)

  • 1. The hypoplastic left heart syndrome - a treatable condition.
    Westerman GR; Norton JB; Van Devanter SH
    J Ark Med Soc; 1984 Jan; 80(8):367-70. PubMed ID: 6229522
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].
    Fujii S; Nagai I; Yonei A; Sari A; Baba K
    Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT; Norton JB; Readinger RI; Sotomora RF
    J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prostaglandin treatment of ductus-dependent congenital heart defects].
    Olsson B; Björkhem G; Lundström NR
    Lakartidningen; 1984 Oct; 81(40):3619-22. PubMed ID: 6541738
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic advances in neonatal cardiology].
    Salazar J; Burgueros M; Peŕez V
    An Esp Pediatr; 1983 Sep; 19 Suppl 18():37-45. PubMed ID: 6685984
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease.
    Ringel RE; Brenner JI; Haney PJ; Burns JE; Moulton AL; Berman MA
    Radiology; 1982 Mar; 142(3):657-8. PubMed ID: 7199748
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
    Kertész E; Hencz P; Tekulics P; Beviz J; Száva J; Matkó I; Kovács G
    Orv Hetil; 1980 May; 121(20):1197-9. PubMed ID: 7413203
    [No Abstract]   [Full Text] [Related]  

  • 9. The ductus arteriosus: why and how to manipulate its patency.
    Drummond WH; Bucciarelli RL; Gessner IH
    J Fla Med Assoc; 1983 Sep; 70(9):788-93. PubMed ID: 6355376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of prostaglandin E1 in the treatment of cyanotic congenital heart defects in infants].
    Dymnicka S; Bielińska B; Ereciński J; Machnowski W
    Pediatr Pol; 1981 Oct; 56(10):1243-8. PubMed ID: 7199703
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent progress in the treatment and prognosis of congenital cardiopathies in early infancy].
    Marcelletti C; Squitieri C; di Donato R
    Pathologica; 1986; 78(1058):731-43. PubMed ID: 3696784
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prostaglandins in the care of the neonate with heart defects].
    Samánek M; Hruda P
    Cesk Pediatr; 1987 Feb; 42(2):71-6. PubMed ID: 3568178
    [No Abstract]   [Full Text] [Related]  

  • 13. Postoperative ketotic hyperglycemia during prostaglandin E1 infusion in infancy.
    Cohen MH; Nihill MR
    Pediatrics; 1983 May; 71(5):842-4. PubMed ID: 6682218
    [No Abstract]   [Full Text] [Related]  

  • 14. [Perfusion with prostaglandins (PGE) in newborn infants with acute cardiopathy].
    Moreno F; Burgueros M; Herraiz I; Quero C; Sánchez PA; Omeñaca F; Martínez A
    Rev Esp Cardiol; 1978; 31(3):335-8. PubMed ID: 674795
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
    Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
    Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of prostaglandins in cardiopulmonary diseases of the newborn.
    Olley PM; Coceani F
    Semin Perinatol; 1980 Apr; 4(2):135-41. PubMed ID: 6990504
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandins in paediatric cardiology.
    Silove ED
    Br J Hosp Med; 1991 May; 45(5):309-10. PubMed ID: 2065237
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical management of infants and children with congenital heart disease.
    Moodie DS
    Cardiovasc Clin; 1981; 12(2):177-86. PubMed ID: 7201345
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
    Olley PM; Coceani F; Rowe RD; Swyer PR
    Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of clinical response to prostaglandin E1 in a cyanotic infant with congenital absence of the ductus arteriosus.
    Hamilton WT; Lacina SJ; Bharati S; Lev M; Arcilla RA
    Cathet Cardiovasc Diagn; 1982; 8(3):273-6. PubMed ID: 7201887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.